Literature DB >> 28926548

Prostate cancer: Potential of PARP inhibition plus ADT in prostate cancer.

Rebecca Kelsey.   

Abstract

Entities:  

Year:  2017        PMID: 28926548     DOI: 10.1038/nrurol.2017.156

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.

Authors:  Mohammad Asim; Firas Tarish; Heather I Zecchini; Kumar Sanjiv; Eleni Gelali; Charles E Massie; Ajoeb Baridi; Anne Y Warren; Wanfeng Zhao; Christoph Ogris; Leigh-Anne McDuffus; Patrice Mascalchi; Greg Shaw; Harveer Dev; Karan Wadhwa; Paul Wijnhoven; Josep V Forment; Scott R Lyons; Andy G Lynch; Cormac O'Neill; Vincent R Zecchini; Paul S Rennie; Aria Baniahmad; Simon Tavaré; Ian G Mills; Yaron Galanty; Nicola Crosetto; Niklas Schultz; David Neal; Thomas Helleday
Journal:  Nat Commun       Date:  2017-08-29       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.